In a landmark move, the World Health Organization has issued its first global guideline for the use of GLP-1-based weight-loss medicines, officially recognizing the drugs as an important tool in modern obesity care. The guidance, released Monday, signals a major policy evolution for the health agency as demand for medications like semaglutide and tirzepatide continues to rise worldwide. The WHO now recommends GLP-1 receptor agonists for adults with a body mass index of 30 or above, or for individuals with a BMI of at least 27 who also live with conditions linked to excess weight, including type 2 diabetes, hypertension, abnormal cholesterol levels, or sleep-related breathing disorders. However, the agency stresses that the drugs must not be used in isolation. According to the guideline, treatment should be delivered as part of a broader clinical plan involving nutrition support, physical activity programs, behavioral counseling, and other medical care where appropriate. The new recommendation is grounded in a comprehensive evidence review, which showed that GLP-1 therapies paired with lifestyle changes consistently produced stronger weight-loss outcomes and improved cardiovascular results compared to lifestyle interventions alone.
Despite the promising data, WHO officials expressed serious concern about limited global availability. The organization warned that high prices and persistent supply shortages have created significant barriers, raising the risk that only wealthier populations will benefit from the treatments. "GLP-1 medicines represent real progress, but they cannot be allowed to widen the gap in global health," said the head of the WHO’s Department of Nutrition and Food Safety. He noted that without sustained efforts to expand access, the global response to obesity could become increasingly unequal. To address these challenges, the guideline urges governments and manufacturers to pursue price negotiations, voluntary licensing, and technology-transfer agreements that would support lower-cost production and improve availability in low- and middle-income countries. The directive also highlights commonly reported side effects such as nausea, vomiting, and constipation, emphasizing the importance of medical supervision throughout treatment. WHO experts caution that the medicines are powerful but require careful monitoring to ensure safe, long-term use. The release of the guideline marks the first time the WHO has formally endorsed a pharmacological approach to obesity on a global scale. With obesity rates continuing to climb across regions, the organization says the new standards are designed to help countries build more effective, equitable, and comprehensive treatment programs.
Science continues to prove that the old adage "you are what you eat" is profoundly true. This is because you have trillions of microorganisms living in your gut, which are directly responsible for nearly every aspect of your health. These microbes make up what’s called your "gut microbiota." They are especially influential in determining your likelihood of gaining excessive weight, becoming obese, and developing obesity-related diseases like diabetes, heart disease, and premature death. The gut microbiome (the expressed genes of your gut microbiota) plays a major role in your metabolism through energy production, storage, and MedicGLP Website expenditure. So, it’s no surprise that science has found a strong connection between gut microbiome imbalance and metabolic syndrome. Yikes! If you have the wrong mix of microbes, daily dietary supplement it could be making it tough for you to get your health on track! Did you know: Scientists can actually look at your gut microbiome composition and tell with 90% accuracy if you are obese or lean. That’s pretty impressive, isn’t it?
1. Unable to lose weight and keep it off? 2. Struggling to fight cravings? 3. Sick of starving yourself for MedicGLP weight loss? 4. Baffled as to why no diet seems to really work for you? Depending on the composition of your gut microbiome, your microbes can either boost your health or weigh you down (figuratively and MedicGLP Website literally). The good news is this: You have control over these little guys with every bite you eat. Diet has the power to change the landscape of your gut microbiome. So, if you’ve tried multiple diets and can’t seem to get the results you want, it’s time to look into your gut microbiome.Will You Lose Weight Naturally on an Individualized Diet? If you’ve been struggling to lose weight and keep it off - it could be your gut microbiome. While Viome doesn’t guarantee weight loss, it has been an exciting result many of our customers have reported. "Fiona’s update day 37!